CYP2C9 and VKORC1 genotyping for the quality of long-standing warfarin treatment in Russian patients-Reference-Cited by-同舟云学术

CYP2C9 and VKORC1 genotyping for the quality of long-standing warfarin treatment in Russian patients

Published:2020-02-06 Issue:5 Volume:20 Page:687-694
ISSN:1470-269X
Container-title:The Pharmacogenomics Journal
language:en
Short-container-title:Pharmacogenomics J

Author:

Panchenko Elizaveta,Kropacheva Ekaterina,Dobrovolsky Anatoly,Titaeva Elena,Zemlyanskaya Oksana,Trofimov Dmitry,Galkina Irina,Lifshits Galina,Vereina Natalya,Sinitsin Sergey,Vorobyeva Nadezda,Grehova Lyudmila,Zateyshchikov Dmitry^ORCID,Zotova Irina,Vavilova Tatyana,Sirotkina Olga,Grontkovskaya Alevtina^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology,Genetics,Molecular Medicine

Link

http://www.nature.com/articles/s41397-020-0157-2.pdf

Reference41 articles.

1. Guyatt GH, Akl EA, Crowther M, Gutterman DD, Schuünemann HJ, American College of Chest Physicians Antithrombotic Therapy and Prevention of Thrombosis Panel Executive summary: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012;2 Suppl:7S–47S.

2. Holbrook AM, Pereira JA, Labiris R, McDonald H, Douketis JD, Crowther M, et al. Systematic overview of warfarin and its drug and food interactions. Arch Intern Med. 2005;165:1095–106.

3. Aithal GP, Day CP, Kesteven PJ, Daly AK. Association of polymorphisms in the cytochrome P450 CYP2C9 with warfarin dose requirement and risk of bleeding complications. Lancet. 1999;353:717–9.

4. D’Andrea G, D’Ambrosio RL, Di Perna P, Chetta M, Santacroce R, Brancaccio V, et al. A polymorphism in the VKORC1 gene is associated with an inter-individual variability in the dose-anticoagulant effect of warfarin. Blood. 2005;105:645–9.

5. Wadelius M, Chen LY, Eriksson N, Bumpstead S, Ghori J, Wadelius C, et al. Association of warfarin dose with genes involved in its action and metabolism. Hum Genet. 2007;121:23–34.

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development of an electrochemical DNA-based biosensor for the detection of the cardiovascular pharmacogenetic-altering SNP CYP2C9*3;Talanta;2023-11

2. Is there still room for warfarin after the appearance of direct oral anticoagulants?;Aterotromboz = Atherothrombosis;2023-01-13

3. The prevalence of VKORC1 alleles in the population of the Republic of Srpska, Bosnia and Herzegovina;Scripta Medica;2023

4. Opposite Response to Vitamin K Antagonists: A Report of Two Cases and Systematic Review of Literature;Journal of Personalized Medicine;2022-09-25

5. Ethnic Diversity and Warfarin Pharmacogenomics;Frontiers in Pharmacology;2022-04-04